At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02359 WUXI APPTEC
Not Yet Opened 10-27 16:08:21
185.600
-2.700
-1.43%
High197.700
Low183.700
Vol10.63M
Open197.700
D1 Closing188.300
Amplitude7.43%
Mkt Cap559.58B
Tradable Cap100.41B
Total Shares3.02B
T/O2.00B
T/O Rate1.97%
Tradable Shares541.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
WuXi AppTec's Q3 Report Stuns Again, So Why Did the Stock Fall Instead of Rising?
China's Three Major Stock Indexes Fluctuate Higher as ChiNext Briefly Gains 1%; Computing Power Hardware Rebounds Selectively, Biopharma Retreats; Hang Seng Tech Opens Higher Then Turns Negative; AI Large Models Rebound with Z.AI Surging 11%
A-shares Fall for Four Straight Weeks, When Will They Stabilize? Flying Cars Ignite Hype, Capital Floods into General Aviation! Real Estate and Pharma Stage Big Rebound, the Truth About WuXi AppTec Emerges
WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The Company conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.